Zur Kurzanzeige

2019-06-04Zeitschriftenartikel DOI: 10.25646/6288
Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality
dc.contributor.authorRoos, Nathalie
dc.contributor.authorLambach, Philipp
dc.contributor.authorMantel, Carsten
dc.contributor.authorMason, Elizabeth
dc.contributor.authorMuñoz, Flor M.
dc.contributor.authorGiles, Michelle
dc.contributor.authorMoran, Allisyn
dc.contributor.authorHombach, Joachim
dc.contributor.authorDiaz, Theresa
dc.contributor.authorMIACSA expert advisory panel group
dc.date.accessioned2019-09-20T09:19:20Z
dc.date.available2019-09-20T09:19:20Z
dc.date.issued2019-06-04none
dc.identifier.other10.1136/bmjopen-2018-024449
dc.identifier.urihttp://edoc.rki.de/176904/6302
dc.description.abstractIntroduction Maternal immunization (MI) with tetanus toxoid containing vaccine, is a safe and cost-effective way of preventing neonatal tetanus. Given the prospect of introducing new maternal vaccines in the near future, it is essential to identify and understand current policies, practices and unmet needs for introducing and/or scaling up MI in low-income and middle-income countries (LMICs). Methods and analysis The Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) is a mixed methods, cross-sectional study that will collect data in four phases: (1) a review of global databases for selected health indicators in 136 LMICs; (2) a structured online survey directed at Maternal, Newborn and Child Health and Expanded Programme on Immunization focal points in all 136 LMICs; (3) semistructured telephone interviews of 30 selected LMICs and (4) 10 week-long country visits, including key informant interviews, health facility visits and focus group discussions. The principal analyses will assess correlations between the various aspects of MI delivery strategies and proxy measures of health systems performance related to vaccine-preventable disease control. The primary outcome will be a typology of existing MI delivery models, and secondary outcomes will include country profiles of child and maternal health indicators, and a MI gaps and needs analysis. Ethics and dissemination The protocol was approved by the WHO Ethics Review Committee (ERC.0002908). The results will be made available in a project report and submitted for publication in peer-reviewed journals that will be shared broadly among global health decisionmakers, researchers, product developers and country-level stakeholders.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectmaternal immunisationeng
dc.subjectmaternal mortalityeng
dc.subjectmaternal tetanuseng
dc.subjectneonatal mortalityeng
dc.subjectneonatal tetanuseng
dc.subjectstudy protocoleng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleMaternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortalitynone
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/6302-8
dc.identifier.doihttp://dx.doi.org/10.25646/6288
dc.type.versionpublishedVersionnone
local.edoc.container-titleBMJ Opennone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://bmjopen.bmj.com/content/9/6/e024449.infonone
local.edoc.container-publisher-nameBMJ Publishingnone
local.edoc.container-volume9none
local.edoc.container-issue6none
local.edoc.container-reportyear2019none
local.edoc.container-year2019none
local.edoc.container-firstpage1none
local.edoc.container-lastpage10none
local.edoc.rki-departmentInfektionsepidemiologienone
dc.description.versionPeer Reviewednone

Zur Kurzanzeige